Foundation Park Building Sells for $12M
Avison Young real estate services announced the sale of a $12 million, newly-constructed 43,180-square-foot biotech and life science research facility at Foundation Park in Alachua. The sale, the largest in Alachua County since 2015 and part of a 1031 exchange, is the first of four buildings that are scheduled to be developed for UF Innovate […]
A Blood Test to Detect Traumatic Brain Injury
Traumatic brain injury (TBI) is hard to detect, and is sometimes called the “invisible injury.” Ron Hayes and Nancy Denslow, both scientists at the McKnight Brain Institute and the founders of UF startup and UF Innovate | Sid Martin Biotech alum Banyan Biomarkers, have developed a blood-based test that will make TBI detection and treatment […]
Ology Bioservices to Adapt Veroplex Cell Platform for Rapid Response to Viral Threats for Department of Defense
The Department of Defense (DOD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense Enabling Biotechnologies has awarded a contract valued at $27.3 million to UF Innovate | Sid Martin Biotech alum Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), to establish their proprietary Veroplex cell platform for rapid response to […]
Ochsner Health and BioInfoExperts Complete First Genomic Sequences of COVID-19 From New Orleans
Scientists from UF Innovate | Sid Martin Biotech startup BioInfoExperts LLC (BIE), a company that provides connected services and technologies related to detecting and monitoring pathogens in communities and the health care industry, and Ochsner Health, have completed the first whole-genome sequences of the SARS-CoV-2 coronavirus from the New Orleans area. By breaking down the virus to its most […]
Sid Martin Startup Alchem Awarded $20.7M for Clinical Trials on Potential COVID-19 Therapies
President Trump has pledged to release billions in funding to fight the coronavirus. Now, information from the Federal Procurement Data System shows well over $3.02 billion has been spent to date, almost half of which has come out of the Health and Human Services (HHS) department. UF Innovate | Sid Martin Biotech startup Alchem Laboratories […]
UF Startup TearClear Appoints Robert J. Dempsey as CEO
UF startup TearClear, a global Ophthalmic Pharmaceutical Company, announced the appointment of Robert J. Dempsey as Chief Executive Officer. TearClear, a resident client at UF Innovate | Sid Martin Biotech, is the only pharmaceutical company to administer preservative-free eye drops to the ocular surface, that are preserved safely prior to dosing. Dempsey, who has more […]
DiaCarta Gets FDA Emergency Use Authorization for Coronavirus PCR Test
UF Innovate | Sid Martin Biotech alum DiaCarta, a molecular diagnostic firm, has obtained the Emergency Use Authorization from the US Food and Drug Administration for its QuantiVirus PCR diagnostic (Dx) test for the novel coronavirus. The test detects the N, Orf1ab, and E genes of the SARS-CoV-2 virus in nasopharyngeal swabs, oropharyngeal swabs, and […]
From Chill to Kill – Pheronym Treated Nematodes Aggressively Disperse in Lower Temperatures
UF Innovate | The Hub and UF Innovate | Sid Martin Biotech alum Pheronym, an ag-biotech pest control company, announced the results of their third peer-reviewed study demonstrating the efficacy of their patented Nematism pheromone extract for bio-remediation of agricultural pests. In a study to be published in Scientific Reports by Springer Nature, Dr. David […]
Ology Bioservices, Inovio Partner To Manufacture COVID-19 DNA Vaccine With $11.9 Million Department of Defense Grant
UF Innovate | Sid Martin Biotech alum Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), and Inovio Pharmaceuticals Inc., a company developing DNA medicines for infectious diseases and cancer, announced that the Department of Defense (DOD) has awarded Ology Bioservices with a contract valued at $11.9 million to work with Inovio on […]
DiaCarta SARS-CoV-2 Test Kit Receives CE Mark
Molecular diagnostic firm and UF Innovate | Sid Martin Biotech alum DiaCarta said that its QuantiVirus SARS-CoV-2 test recently received the CE mark. The firm has also filed for Emergency Use Authorization of the test with the US Food and Drug Administration. The company’s qRT-PCR test detects viral RNA extracted from nasopharyngeal swabs, oropharyngeal swabs, […]